ANN WALKER

Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act S. 778/H.R. 1854, The Prescription Drug Monitoring Act

Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act

Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 214, The Preserve Access to Affordable Generics Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act H.R. 2051, The Fair Access for Safe and Timely Generics Act S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act

Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 214 Preserve Access to Affordable Generics Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act

Issues related to Medicare Part D and Medicare payment for home infusion. S.637, The Creating Transparency to Have Drug Rebates Unlocked Act S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act

Issues related to Medicare Part D and Medicare payment for home infusion. S.637, The Creating Transparency to Have Drug Rebates Unlocked Act S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act

Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act

Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act S. 778/H.R. 1854, The Prescription Drug Monitoring Act

Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act S. 778/H.R. 1854, The Prescription Drug Monitoring Act

Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 214, The Preserve Access to Affordable Generics Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act H.R. 2051, The Fair Access for Safe and Timely Generics Act S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act

Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 214, The Preserve Access to Affordable Generics Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act H.R. 2051, The Fair Access for Safe and Timely Generics Act S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act

Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act S. 778/H.R. 1854, The Prescription Drug Monitoring Act

Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act

Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act S. 778/H.R. 1854, The Prescription Drug Monitoring Act

Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act

Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act S. 778/H.R. 1854, The Prescription Drug Monitoring Act

Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act

Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act S. 778/H.R. 1854, The Prescription Drug Monitoring Act

Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act

Issues related to Medicare Part D and Medicare payment for home infusion. S.637, The Creating Transparency to Have Drug Rebates Unlocked Act S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act

Issues related to Medicare Part D and Medicare payment for home infusion. S.637, The Creating Transparency to Have Drug Rebates Unlocked Act S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act

Issues related to Medicare Part D and Medicare payment for home infusion. S.637, The Creating Transparency to Have Drug Rebates Unlocked Act S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act

Issues related to Medicare Part D and Medicare payment for home infusion. S.637, The Creating Transparency to Have Drug Rebates Unlocked Act S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act

Issues related to corporate tax reform. S.638/H.R.1296, The Promoting More American Manufacturing Jobs Act

Issues related to corporate tax reform. S.638/H.R.1296, The Promoting More American Manufacturing Jobs Act

Issues related to Medicare Part D and Medicare payment for home infusion. S.637, The Creating Transparency to Have Drug Rebates Unlocked Act S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act

Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act

Issues related to Medicare Part D and Medicare payment for home infusion. S.637, The Creating Transparency to Have Drug Rebates Unlocked Act S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act

Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 214, The Preserve Access to Affordable Generics Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act H.R. 2051, The Fair Access for Safe and Timely Generics Act S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act

Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 214 Preserve Access to Affordable Generics Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act

Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act S. 778/H.R. 1854, The Prescription Drug Monitoring Act

Issues related to medication adherence, generic drug approvals, biologic exclusivity periods, and drug price transparency. H.R.592/S.109, The Pharmacy and Medically Underserved Areas Enhancement Act H.R.1316, The Prescription Drug Price Transparency Act S.771/H.R. 1776, The Improving Access To Affordable Prescription Drugs Act H.R.749, The Lower Drug Costs Through Competition Act S. 297, The Increasing Competition in Pharmaceuticals Act S. 778/H.R. 1854, The Prescription Drug Monitoring Act

Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 214, The Preserve Access to Affordable Generics Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act H.R. 2051, The Fair Access for Safe and Timely Generics Act S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act

Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 214 Preserve Access to Affordable Generics Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act

Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 214, The Preserve Access to Affordable Generics Act S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act H.R. 2051, The Fair Access for Safe and Timely Generics Act S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, drug pricing and Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S. 524-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, 340B, drug pricing and drug supply chain safety & Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 1735-National Defense Authorization Act for Fiscal Year 2016 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

Issues related to prescription drug abuse, preferred pharmacy networks, medication adherence, and drug pricing. Issues related to FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S. 524, HR 953-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act S.3056-the Creating and Restoring Equal Access to Equivalent Samples Act (CREATES)

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, 340B, drug pricing and drug supply chain safety & Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 1735-National Defense Authorization Act for Fiscal Year 2016 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, drug pricing and Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S. 524-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, 340B, drug pricing and drug supply chain safety & Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 1735-National Defense Authorization Act for Fiscal Year 2016 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

Issues related to smoking cessation, Medicare Part D, contraceptive coverage and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment, medication adherence, restrictions on PBM cost saving tools like mail order, generics and restrictions on PBM audit practices. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology

Issues related to smoking cessation, Medicare Part D and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment and medication adherence. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology H.R. 2712,Commonsense Reporting and Verification Act of 2015 S. 1996, Commonsense Reporting Act of 2015

Issues related to prescription drug abuse, preferred pharmacy networks, medication adherence, and drug pricing. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S.3056-the Creating and Restoring Equal Access to Equivalent Samples Act (CREATES)

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, drug pricing and Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S. 524-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, 340B, drug pricing and drug supply chain safety & Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 1735-National Defense Authorization Act for Fiscal Year 2016 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

Issues related to prescription drug abuse, preferred pharmacy networks, medication adherence, and drug pricing. Issues related to FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S. 524, HR 953-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act S.3056-the Creating and Restoring Equal Access to Equivalent Samples Act (CREATES)

Issues related to implementation of Section 1557 of ACA HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act

Issues related to smoking cessation, Medicare Part D, contraceptive coverage and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment, medication adherence, restrictions on PBM cost saving tools like mail order, generics and restrictions on PBM audit practices. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology

Issues related to smoking cessation, Medicare Part D and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment and medication adherence. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology H.R. 2712,Commonsense Reporting and Verification Act of 2015 S. 1996, Commonsense Reporting Act of 2015

HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 4062 - Protecting Seniors Access to Proper Care Act of 2015 HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act H.R. 5951-Improving Transparency and Accuracy in Medicare Part D Spending Act

H.R.2712-Commonsense Reporting and Verification Act of 2015 S.1996-Commonsense Reporting Act of 2015 H.R.34 - 21st Century Cures Act (H.R.6) S.533-Tsunami Warning, Education, and Research Act of 2015 (21st Century Cures Act)

Issues related to smoking cessation, Medicare Part D and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment and medication adherence. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology H.R. 2712,Commonsense Reporting and Verification Act of 2015 S. 1996, Commonsense Reporting Act of 2015

H.R.2712-Commonsense Reporting and Verification Act of 2015 S.1996-Commonsense Reporting Act of 2015 H.R.34 - 21st Century Cures Act (H.R.6) S.533-Tsunami Warning, Education, and Research Act of 2015 (21st Century Cures Act)

Issues related to restructuring of corporate tax rates. HR 3763-Surface Transportation Reauthorization & Reform Act of 2015

HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 4062 - Protecting Seniors Access to Proper Care Act of 2015 HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act H.R. 5951-Improving Transparency and Accuracy in Medicare Part D Spending Act

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, drug pricing and Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S. 524-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, 340B, drug pricing and drug supply chain safety & Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 1735-National Defense Authorization Act for Fiscal Year 2016 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

Issues related to restructuring of corporate tax rates. HR4770-To amend the Internal Revenue Code of 1986 to provide appropriate rules for the application of the deduction for income attributable to domestic production activities with respect to certain contract manufacturing or production arrangements. S.3517-Promoting More American Manufacturing Jobs Act

Issues related to restructuring of corporate tax rates. HR4770-To amend the Internal Revenue Code of 1986 to provide appropriate rules for the application of the deduction for income attributable to domestic production activities with respect to certain contract manufacturing or production arrangements

Issues related to restructuring of corporate tax rates. HR4770-To amend the Internal Revenue Code of 1986 to provide appropriate rules for the application of the deduction for income attributable to domestic production activities with respect to certain contract manufacturing or production arrangements

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, drug pricing and Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S. 524-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act

Issues related to prescription drug abuse, preferred pharmacy networks, medication adherence, and drug pricing. Issues related to FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S. 524, HR 953-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act S.3056-the Creating and Restoring Equal Access to Equivalent Samples Act (CREATES)

S.3094 , H.R.5573-Price Relief, Innovation, and Competition for Essential Drugs Act (PRICED)

S.3094 , H.R.5573-Price Relief, Innovation, and Competition for Essential Drugs Act (PRICED)

Issues related to prescription drug abuse, preferred pharmacy networks, medication adherence, and drug pricing. Issues related to FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S. 524, HR 953-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act S.3056-the Creating and Restoring Equal Access to Equivalent Samples Act (CREATES)

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, 340B, drug pricing and drug supply chain safety & Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 1735-National Defense Authorization Act for Fiscal Year 2016 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

Issues related to prescription drug abuse, preferred pharmacy networks, medication adherence, and drug pricing. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S.3056-the Creating and Restoring Equal Access to Equivalent Samples Act (CREATES)

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, drug pricing and Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S. 524-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act

HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 4062 - Protecting Seniors Access to Proper Care Act of 2015 HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act H.R. 5951-Improving Transparency and Accuracy in Medicare Part D Spending Act

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, 340B, drug pricing and drug supply chain safety & Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 1735-National Defense Authorization Act for Fiscal Year 2016 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

H.R.2712-Commonsense Reporting and Verification Act of 2015 S.1996-Commonsense Reporting Act of 2015 H.R.34 - 21st Century Cures Act (H.R.6) S.533-Tsunami Warning, Education, and Research Act of 2015 (21st Century Cures Act)

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, drug pricing and Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S. 524-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act

Issues related to smoking cessation, Medicare Part D, contraceptive coverage and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment, medication adherence, restrictions on PBM cost saving tools like mail order, generics and restrictions on PBM audit practices. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology

HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 4062 - Protecting Seniors Access to Proper Care Act of 2015 HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act H.R. 5951-Improving Transparency and Accuracy in Medicare Part D Spending Act

Issues related to implementation of Section 1557 of ACA HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act

Issues related to smoking cessation, Medicare Part D and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment and medication adherence. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology H.R. 2712,Commonsense Reporting and Verification Act of 2015 S. 1996, Commonsense Reporting Act of 2015

Medicare/Medicaid-Issues related to plan design, reimbursement, audit and cost savings proposals. Issues related to Part D Prescriber enrollment. HR 793 - Ensuring Seniors Access to Local Pharmacies Act

Medicare/Medicaid-Issues related to plan design, reimbursement, audit and cost savings proposals. Issues related to Part D prescriber enrollment. HR 793 - Ensuring Seniors Access to Local Pharmacies Act

HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 4062 - Protecting Seniors Access to Proper Care Act of 2015 HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act H.R. 5951-Improving Transparency and Accuracy in Medicare Part D Spending Act

Issues related to smoking cessation, Medicare Part D and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment and medication adherence. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology H.R. 2712,Commonsense Reporting and Verification Act of 2015 S. 1996, Commonsense Reporting Act of 2015

Issues related to implementation of Section 1557 of ACA HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act

Issues related to smoking cessation, Medicare Part D, contraceptive coverage and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment, medication adherence, restrictions on PBM cost saving tools like mail order, generics and restrictions on PBM audit practices. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology

Issues related to prescription drug abuse, preferred pharmacy networks, medication adherence, and drug pricing. Issues related to FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S. 524, HR 953-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act S.3056-the Creating and Restoring Equal Access to Equivalent Samples Act (CREATES)

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, 340B, drug pricing and drug supply chain safety & Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 1735-National Defense Authorization Act for Fiscal Year 2016 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, drug pricing and Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S. 524-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act

H.R.2712-Commonsense Reporting and Verification Act of 2015 S.1996-Commonsense Reporting Act of 2015 H.R.34 - 21st Century Cures Act (H.R.6) S.533-Tsunami Warning, Education, and Research Act of 2015 (21st Century Cures Act)

Issues related to smoking cessation, Medicare Part D and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment and medication adherence. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology H.R. 2712,Commonsense Reporting and Verification Act of 2015 S. 1996, Commonsense Reporting Act of 2015

Issues related to smoking cessation, Medicare Part D, contraceptive coverage and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment, medication adherence, restrictions on PBM cost saving tools like mail order, generics and restrictions on PBM audit practices. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology

Issues related to smoking cessation, Medicare Part D and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment and medication adherence. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology H.R. 2712,Commonsense Reporting and Verification Act of 2015 S. 1996, Commonsense Reporting Act of 2015

Issues related to smoking cessation, Medicare Part D, contraceptive coverage and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment, medication adherence, restrictions on PBM cost saving tools like mail order, generics and restrictions on PBM audit practices. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology

Issues related to smoking cessation, Medicare Part D and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment and medication adherence. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology H.R. 2712,Commonsense Reporting and Verification Act of 2015 S. 1996, Commonsense Reporting Act of 2015

HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 4062 - Protecting Seniors Access to Proper Care Act of 2015 HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act H.R. 5951-Improving Transparency and Accuracy in Medicare Part D Spending Act

Issues related to implementation of Section 1557 of ACA HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act

Issues related to prescription drug abuse, preferred pharmacy networks, medication adherence, and drug pricing. Issues related to FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S. 524, HR 953-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act S.3056-the Creating and Restoring Equal Access to Equivalent Samples Act (CREATES)

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, drug pricing and Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S. 524-Comprehensive Addiction and Recovery Act HR 4909-National Defense Authorization Act S 2943--National Defense Authorization Act